Search research articles
Contact Us
Filters
Showing results (161-170 of 166) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 166 results.
Respiratory Medicine
|
April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease
Giulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Annals of the American Thoracic Society
|
December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease
Alyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Respiratory Medicine
|
December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune features
Sana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Respirology (Carlton, Vic.)
|
May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
Cathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society
|
June 28, 2016
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study
Christopher J Ryerson, Pat G Camp, Neil D Eves, et al.
The European Respiratory Journal
|
March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 166) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 166 results.
Respiratory Medicine
|
April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease
Giulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Annals of the American Thoracic Society
|
December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease
Alyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Respiratory Medicine
|
December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune features
Sana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Respirology (Carlton, Vic.)
|
May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
Cathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society
|
June 28, 2016
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study
Christopher J Ryerson, Pat G Camp, Neil D Eves, et al.
The European Respiratory Journal
|
March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Page
of 17